RNXT
RenovoRx Inc
1.60$
+1.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | |
| – | – | – | – | – | 0.0% | 29.1% | |
| – | – | – | – | – | 100.0% | 70.9% | |
| – | – | – | – | – | 14,011.6% | 558.2% | |
| – | – | – | – | – | 11,600.0% | 626.6% | |
| – | – | – | – | – | 25,611.6% | 1,184.9% | |
| – | – | – | – | – | -25,511.6% | -1,114.0% | |
| – | – | – | – | – | 893.0% | – | |
| – | – | – | – | – | -20,497.7% | -994.5% | |
| – | – | – | – | – | -20,497.7% | – | |
| – | – | – | – | – | -20,497.7% | -994.5% | |
| – | – | – | – | – | -20,497.7% | -994.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.